HK1208498A1 - Method and composition for preventing stem cell disruption and aggregation - Google Patents

Method and composition for preventing stem cell disruption and aggregation

Info

Publication number
HK1208498A1
HK1208498A1 HK15109256.3A HK15109256A HK1208498A1 HK 1208498 A1 HK1208498 A1 HK 1208498A1 HK 15109256 A HK15109256 A HK 15109256A HK 1208498 A1 HK1208498 A1 HK 1208498A1
Authority
HK
Hong Kong
Prior art keywords
aggregation
composition
stem cell
cell disruption
preventing stem
Prior art date
Application number
HK15109256.3A
Other languages
English (en)
Chinese (zh)
Inventor
羅廷燦
姜成根
申燮
Original Assignee
Stemcell Co Ltd K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stemcell Co Ltd K filed Critical Stemcell Co Ltd K
Publication of HK1208498A1 publication Critical patent/HK1208498A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0607—Non-embryonic pluripotent stem cells, e.g. MASC
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C12N2501/71—Oxidoreductases (EC 1.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999—Small molecules not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
HK15109256.3A 2012-04-13 2015-09-21 Method and composition for preventing stem cell disruption and aggregation HK1208498A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20120038828 2012-04-13
PCT/KR2013/003141 WO2013154404A1 (ko) 2012-04-13 2013-04-15 줄기세포의 파쇄 및 응집 방지 방법 및 조성물

Publications (1)

Publication Number Publication Date
HK1208498A1 true HK1208498A1 (en) 2016-03-04

Family

ID=49327896

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15109256.3A HK1208498A1 (en) 2012-04-13 2015-09-21 Method and composition for preventing stem cell disruption and aggregation

Country Status (10)

Country Link
US (1) US9433645B2 (es)
EP (1) EP2837682B1 (es)
JP (1) JP5931277B2 (es)
KR (1) KR101467481B1 (es)
CN (1) CN104755609B (es)
AU (1) AU2013247455A1 (es)
HK (1) HK1208498A1 (es)
MX (1) MX359002B (es)
WO (1) WO2013154404A1 (es)
ZA (1) ZA201407412B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013250089B2 (en) * 2012-04-18 2016-08-18 R Bio Co., Ltd. Method for manufacturing stem cell having appropriate size for intravascular administration
KR101583569B1 (ko) * 2013-05-15 2016-01-08 라정찬 정맥 투여용 줄기세포 조성물
CA2974620C (en) 2015-01-29 2021-06-22 The University Of Tokyo Cell culture method, cell aggregates, cell aggregation control agent, and medium
KR101648915B1 (ko) 2016-05-16 2016-08-17 주식회사 디지레이 줄기세포의 응집방지 방법 및 그 조성물
US11788061B2 (en) 2016-07-29 2023-10-17 Jeong Chan Ra Method for producing mesenchymal stem cells that inhibit proliferation of cancer cells
EP3492578B1 (en) * 2016-12-27 2021-05-12 Fullstem Co., Ltd. Method for harvesting cultured cells from three-dimensional porous scaffold
EP3608400A4 (en) * 2017-04-03 2021-01-06 Kaneka Corporation CELL POPULATION WITH MESENCHYMAL STEM CELLS, METHOD OF MANUFACTURING THEREFORE AND PHARMACEUTICAL COMPOSITION
US11692172B2 (en) * 2017-06-26 2023-07-04 Mackay Memorial Hosptal Formulation comprising extracellular vesicles, method for producing the same, and uses thereof
CN109423476A (zh) * 2017-08-21 2019-03-05 青岛瑞思德生物科技有限公司 用于制备脂肪间充质干细胞的试剂盒
KR102233568B1 (ko) * 2019-12-13 2021-03-30 주식회사 알바이오 항암 바이러스가 도입된 중간엽 줄기세포의 세포 생존능을 향상시키는 방법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2469370C (en) 2001-12-07 2014-07-08 Macropore Biosurgery, Inc. Adipose-derived cell processing unit
MXPA05009044A (es) * 2003-02-20 2006-03-17 Macropore Biosurgery Inc Metodos para utilizar celulas derivadas de tejido adiposo en el tratamiento de condiciones cardiovasculares.
WO2005011569A2 (en) * 2003-06-18 2005-02-10 Macropore Biosurgery Inc. Methods of using adipose tissue-derived cells in augmenting autologous fat transfer
EP2597149A1 (en) 2004-08-16 2013-05-29 CellResearch Corporation Pte Ltd Isolation, cultivation and uses of stem/progenitor cells
KR100818214B1 (ko) 2006-09-29 2008-04-01 재단법인서울대학교산학협력재단 인간 태반조직의 양막 또는 탈락막 유래 다분화능 줄기세포및 그 제조방법
KR100795708B1 (ko) 2006-12-26 2008-01-17 주식회사 알앤엘바이오 인간 양막 상피세포 유래 성체 줄기세포의 분리 및 배양방법
ES2325715B1 (es) * 2007-08-03 2010-06-17 Genetrix, S.L. Poblacion de celulas madre adultas derivadas de tejido adiposo cardiaco y su uso en regeneracion cardiaca.
EP2393353A4 (en) * 2009-02-05 2013-12-25 Resolvyx Pharmaceuticals Inc COMPOSITIONS AND METHODS OF ORGAN CONSERVATION
US20120263685A1 (en) * 2009-10-08 2012-10-18 Rnl Bio Co., Ltd Anti-tumor composition comprising human-derived adult stem cells
US20120020931A1 (en) * 2010-06-02 2012-01-26 Rutgers, The State University Of New Jersey Therapeutic encapsulated embryonic stem cells and mesenchymal stromal cells
US20130330300A1 (en) * 2010-07-20 2013-12-12 University Of Southern California High Telomerase Activity Bone Marrow Mesenchymal Stem Cells, Methods of Producing the Same and Pharmaceuticals and Treatment Methods Based Thereon
KR101293637B1 (ko) * 2011-01-14 2013-08-13 서울대학교병원 줄기세포의 부유배양용 조성물

Also Published As

Publication number Publication date
MX2014012260A (es) 2015-07-14
KR101467481B1 (ko) 2014-12-01
EP2837682B1 (en) 2017-09-20
ZA201407412B (en) 2016-09-28
KR20130116213A (ko) 2013-10-23
MX359002B (es) 2018-09-12
US9433645B2 (en) 2016-09-06
CN104755609A (zh) 2015-07-01
EP2837682A1 (en) 2015-02-18
JP2015513918A (ja) 2015-05-18
AU2013247455A1 (en) 2014-11-20
EP2837682A4 (en) 2015-09-02
US20150118194A1 (en) 2015-04-30
JP5931277B2 (ja) 2016-06-08
CN104755609B (zh) 2017-09-05
WO2013154404A1 (ko) 2013-10-17

Similar Documents

Publication Publication Date Title
HK1208498A1 (en) Method and composition for preventing stem cell disruption and aggregation
EP2908629A4 (en) COMPOSITIONS AND METHODS FOR RECRUITING AND LOCATING STEM CELLS
IL236679A0 (en) Preparations and methods for regulating car t cells
SG11201500329WA (en) Stem cell microparticles
SG11201406336YA (en) Stem cell microparticles
SG11201508027PA (en) Methods and compositions for mobilizing stem cells
EP2831939A4 (en) ELECTRODE FOR ENERGY STORAGE DEVICES AND METHOD FOR MANUFACTURING SAME
GB201122195D0 (en) Composition and method
GB201408236D0 (en) Composition and method
EP2790259A4 (en) SECONDARY BATTERY AND MANUFACTURING METHOD THEREFOR
EP2869360A4 (en) BATTERY AND MANUFACTURING METHOD THEREFOR
GB201214704D0 (en) Stem cell culture method
HK1212733A1 (zh) 富含維生素發酵物的組合物和方法
SG11201408326TA (en) Preparation method for perfluoro-2-methyl-3-pentanone and intermediate
EP2854562A4 (en) FOOD COMPOSITION AND METHOD
EP2844272A4 (en) METHOD AND COMPOSITIONS FOR INCREASING RED BLOOD BODIES
EP2704480A4 (en) METHOD AND DEVICE FOR CONTROLLING A CELL RESOLUTION
EP2915880A4 (en) MAIT CELLS AND METHOD FOR THE PRODUCTION THEREOF
EP2823038A4 (en) PLACENTAL STEM CELLS, METHODS OF ISOLATING THESE CELLS AND USE THEREOF
HK1209650A1 (en) Method and composition for metabolic regulation
GB201106433D0 (en) Composition and method
HK1209617A1 (en) Composition for promoting cell regeneration and preparation method and purpose thereof
IL239529B (en) Preparations and methods for creating improved and different cells and organisms
GB201222820D0 (en) Woolscouring method and composition
EP2910778A4 (en) WINDMILL AND METHOD FOR OPERATING THE SAME